Oct 2020 | Poxel Announces Positive Results From Phase 2a NASH Trial With PXL770, an Oral First-in-Class Direct AMPK Activator 12 October, 2020
Aug. 2020 | Adocia was granted a State-guaranteed loan (PGE) for EUR 7 million associated with a rescheduling of loan terms contracted with IPF Partners in 2019 12 October, 2020
Aug. 2020 | Lumeon Raises $30M in Funding to Support U.S. Growth with participation from IPF Partners 16 September, 2020
June 2020 | Poxel Announces Positive Pharmacokinetic (PK) / Pharmacodynamic (PD) Study Results for PXL770, a Direct AMPK Activator for the Treatment of NASH 16 September, 2020
